Oligonucleotides are commonly used as primers for polymerase chain reaction (PCR), PCR assays, and panels for biologically related genes. Antisense oligonucleotides are used to reduce levels of protein synthesis by inhibiting mRNA processing or translation. Other uses of oligonucleotides include DNA sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), and nucleic acid aptamers. Moreover, many pharmaceutical companies are focusing on developing nucleic acid-based therapeutics due to which the demand of oligonucleotide is increasing. Hence, market players are focusing on expanding their manufacturing facilities, which is expected to boost the market growth over the forecast period. For instance, in August 2020, Agilent Technologies Inc., announced the expansion of its state-of-the-art production facility in Frederick, Colorado, which develops manufactures oligos that hold potential to be used as treatments for diseases such as COVID-19, cardiovascular disease, cancer, rare and infectious diseases, and other conditions.
Market Dynamics:
Key players are focusing on various inorganic growth strategies such as collaborations, partnerships and agreements, which is expected to propel the growth of the global oligonucleotide synthesis market during the forecast period. For instance, on August 05, 2020, Evotec SE, a drug discovery and development company entered into a strategic partnership with Secarna Pharmaceuticals GmbH & Co. KG, a drug discovery company, for the development of antisense oligonucleotide therapies.
Moreover, in November 2019, CSBio, a peptide and instrumentation manufacturing company entered into a collaboration with Sunresin, a supplier of ion exchange resin and absorption & separation resin for the development of an optimized polystyrene resin for commercial scale oligonucleotide synthesis.
Key features of the study:
- This report provides in-depth analysis of the global oligonucleotide synthesis market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global oligonucleotide synthesis market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
- Key companies covered as a part of this study include Thermo Fisher Scientific, Sigma-Aldrich Corporation, GE Healthcare, Integrated DNA Technologies, Inc., TriLink BioTechnologies, Inc, BioAutomation Corporation, Twist Bioscience, Shanghai SynTheAll Pharmaceutical Co., CUSABIO Technology LLC, Synbio Technologies, GENEWIZ, Eurofins Scientific, Agilent Technologies, Kaneka Eurogentec S.A., and LGC, Biosearch Technologies
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, market expansion, and marketing tactics
- The global oligonucleotide synthesis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oligonucleotide synthesis market.
Detailed Segmentation:
- Global Oligonucleotide Synthesis Market, By Equipment & Services:
- Equipment/Synthesizer
- Reagents
- Services
- Oligo Synthesis
- Modification
- Purification
- Global Oligonucleotide Synthesis Market, By Technology:
- Column-based
- Microarray-based
- Global Oligonucleotide Synthesis Market, By Nucleic Acid Type:
- Global Oligonucleotide Synthesis Market, By Application:
- Drug Discovery
- Therapeutics
- Global Oligonucleotide Synthesis Market, By End User:
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-Biotechnology Companies
- Global Oligonucleotide Synthesis Market, By Region:
- North America
- By Equipment & Services
- Equipment/Synthesizer
- Reagents
- Services
- Oligo Synthesis
- Modification
- Purification
- By Technology
- Column-based
- Microarray-based
- By Nucleic Acid Type
- By Application
- Drug Discovery
- Therapeutics
- By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-Biotechnology Companies
- By Country:
- Latin America
- By Equipment & Services
- Equipment/Synthesizer
- Reagents
- Services
- Oligo Synthesis
- Modification
- Purification
- By Technology
- Column-based
- Microarray-based
- By Nucleic Acid Type
- By Application
- Drug Discovery
- Therapeutics
- By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-Biotechnology Companies
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Equipment & Services
- Equipment/Synthesizer
- Reagents
- Services
- Oligo Synthesis
- Modification
- Purification
- By Technology
- Column-based
- Microarray-based
- By Nucleic Acid Type
- By Application
- Drug Discovery
- Therapeutics
- By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-Biotechnology Companies
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Equipment & Services
- Equipment/Synthesizer
- Reagents
- Services
- Oligo Synthesis
- Modification
- Purification
- By Technology
- Column-based
- Microarray-based
- By Nucleic Acid Type
- By Application
- Drug Discovery
- Therapeutics
- By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-Biotechnology Companies
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Equipment & Services
- Equipment/Synthesizer
- Reagents
- Services
- Oligo Synthesis
- Modification
- Purification
- By Technology
- Column-based
- Microarray-based
- By Nucleic Acid Type
- By Application
- Drug Discovery
- Therapeutics
- By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-Biotechnology Companies
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Equipment & Services
- Equipment/Synthesizer
- Reagents
- Services
- Oligo Synthesis
- Modification
- Purification
- By Technology
- Column-based
- Microarray-based
- By Nucleic Acid Type
- By Application
- Drug Discovery
- Therapeutics
- By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-Biotechnology Companies
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Thermo Fisher Scientific
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sigma-Aldrich Corporation
- GE Healthcare
- Integrated DNA Technologies, Inc.
- TriLink BioTechnologies, Inc
- BioAutomation Corporation
- Twist Bioscience
- Shanghai SynTheAll Pharmaceutical Co.
- CUSABIO Technology LLC
- Synbio Technologies
- GENEWIZ
- Eurofins Scientific
- Agilent Technologies
- Kaneka Eurogentec S.A.
- LGC, Biosearch Technologies
“*” marked represents similar segmentation in other categories in the respective section.
